Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy

Cardiovascular Drugs and Therapy

Volumn 14, Issue 6, 2000, Pages 643-650

  Dimitrow, P P ^a   Krzanowski, M ^a   Nizankowski, R ^a   Szczeklik, A ^a   Dubiel, J S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Endothelium dependent vasodilatation; Hypertrophic cardiomyopathy; Propranolol; Verapamil

Indexed keywords

PROPRANOLOL; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; COLD PRESSOR TEST; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY VASCULAR RESISTANCE; DOPPLER ECHOGRAPHY; FEMALE; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOMYOPATHY, HYPERTROPHIC; COLD; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; PRESSURE; PROPRANOLOL; VASCULAR RESISTANCE; VERAPAMIL;

EID: 0034466735     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007871032421     Document Type: Article

References (53)

1. The management of hypertrophic cardiomyopathy
2. Treatment of hypertrophic cardiomyopathy with verapamil
3. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: Results of a multicenter study
4. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology and therapy
5. Verapamil therapy: A new approach to the pharamcologic treatment of hypertrophic cardiomyopathy: II Effects on exercise and symptomatic status
6. Effects of verapamil on left ventricular systolic function diastolic filling in patients with hypertrophic cardiomyopathy
7. Diastolic function in hypertrophic cardiomyopathy: Effects of propranolol and verapamil on diastolic stiffness
8. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: Short- and long-term effects
9. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopatthies
10. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy
11. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy
12. Intramural ("small vessel") coronary disease in hypertrophic cardiomyopathy
13. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy
14. Alterations of architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: A possible cause for myocardial ischemia
15. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation
16. Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy effect of treatment
17. Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy
18. Reversal of abnormal coronary vasomotion by calcium antagonists in patients with hypercholesterolemia
19. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension
20. Dilatation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test
21. Modulation of coronary vasomotor tone: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis
22. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis
23. Coronary vasomotion in response to sympathetic stimulation in humans: Importance of the functional integrity of the endothelium
24. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease
25. Clinical characteristics in Japanese patients with coexistent hypertrophic cardiomyopathy and coronary vasospasm
26. Verapamil improves the response of coronary vasomotion to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy
27. Assessment of endothelium dependent coronary vasodilatation in hypertrophic cardiomyopathy
28. Report of World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
29. Hypertrophic cardiomyopathy: A discussion of nomenclature
30. Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy
31. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography. Comparison with invasive technique
32. New noninvasive method for coronary flow reserve assessment: Contrast-enhanced transthoracic second harmonic echo Doppler
33. Effects of various doses of intracoronary verapamil on coronary resistance vessels in humans
34. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy
35. Does pharmacologic coronary flow reserve reflect vasodilator responsiveness to increased myocardial demand in humans?
36. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension
37. Comparison of the effects of exercise and cold pressor test on the vasomotor response of normal and atherosclerotic coronary arteries and their relation to the flow-mediated mechanism
38. Effect of nitric oxide synthesis inhibition on the coronary sinus blood flow response to the cold pressor test: Evaluation by transthoracic echocardiography
39. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease
40. The myocardial oxygen/demand ratio in patients with and without coronary artery disease
41. L-arginine normalizes coronary vasomotion in long-term smokers
42. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency, effect of verapamil and trandolapril
43. Calcium-channel blockers preserve endothelial reactivity after ischemia-reperfusion
44. Effects of quinide and verapamil on human cardiovascular alpha 1-adrenoceptors
45. Interactions between calcium channel blockers and alpha-adrenoceptors in the human coronary and mammary arteries: A radioligand binding study
46. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines
47. Augmented α-adrenergic constriction of atherosclerotic human coronary arteries
48. Interdependence of pharmacologically-induced and endothelium-mediated coronary vasodilatation in antianginal therapy
49. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: Studies in perfused mesenteric resistance arteries
50. Different potencies of endothelium-derived relaxing factors against thromboxane and endothelin-1 in coronary arteries: Comparison with nitrovasodilator calcium antagonists
51. Effect of diltiazem and verapamil on endothelin release by cultured human coronary smooth-muscle cells and endothelial cells
52. Transluminal subselective measurement of coronary artery flow velocity and vasodilator reserve in man
53. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study